Dabigatran Etexilate 67877-0475-60
- Manufacturer
- Ascend Laboratories, Llc
- Dosage Form
- Capsule, Coated Pellets
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 20, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208040
Need to source Dabigatran Etexilate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabigatran Etexilate Mesylate | 150 mg/1 |
Drug Class
Direct Thrombin Inhibitor [EPC]Thrombin Inhibitors [MoA]
Selected Package
67877-0475-60Selected60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-475-60)